CMV Risk Higher For Patients With Systemic Lupus Erythematosus Treated With Immunosuppressive Therapies, Study Finds

Infectious Disease Advisor (6/22, Mermelstein) reports patients with active systemic lupus erythematosus who are treated with “immunosuppressive therapy are at risk of developing cytomegalovirus (CMV) infection due to an attenuated CMV-specific immune res...